Vijaya Diagnostic Centre Board Meeting Scheduled for February 13, 2026 to Review Q3FY26 Financial Results
Vijaya Diagnostic Centre Limited has scheduled a board meeting for February 13, 2026, to consider and approve standalone and consolidated unaudited financial results for Q3FY26 and nine months ended December 31, 2025. The company has implemented trading window restrictions from January 01, 2026, until February 15, 2026, affecting designated persons and their immediate relatives. The meeting notification complies with SEBI Listing Regulations and was communicated to both NSE and BSE exchanges.

*this image is generated using AI for illustrative purposes only.
Vijaya Diagnostic Centre Limited has formally notified stock exchanges about an upcoming board meeting scheduled to review its third quarter financial performance for FY26. The meeting represents a key milestone in the company's quarterly reporting cycle and regulatory compliance obligations.
Board Meeting Details
The board of directors will convene on Friday, February 13, 2026, to deliberate on critical financial and corporate matters. The meeting agenda encompasses comprehensive review of the company's financial performance for the recently concluded quarter.
| Meeting Parameter: | Details |
|---|---|
| Date: | Friday, February 13, 2026 |
| Primary Agenda: | Q3FY26 unaudited financial results |
| Reporting Period: | Quarter and nine months ended December 31, 2025 |
| Result Type: | Standalone and consolidated |
Financial Results Review
The board will consider and approve both standalone and consolidated unaudited financial results for the third quarter and nine months ended December 31, 2025. This comprehensive financial review will provide stakeholders with insights into the company's operational performance across different business segments and geographical regions.
The meeting will also address other corporate matters, though specific details of these additional agenda items have not been disclosed in the regulatory filing.
Trading Window Restrictions
Vijaya Diagnostic Centre has implemented mandatory trading window restrictions in compliance with regulatory requirements. The trading window closure affects all designated persons and their immediate relatives, ensuring adherence to insider trading prevention measures.
| Restriction Parameter: | Timeline |
|---|---|
| Closure Start Date: | January 01, 2026 |
| Closure End Date: | February 15, 2026 |
| Duration: | Until 48 hours after results announcement |
| Affected Parties: | Designated persons and immediate relatives |
The trading window closure was initially communicated to exchanges on December 24, 2025, providing advance notice to all stakeholders about the upcoming restrictions. This proactive approach demonstrates the company's commitment to regulatory compliance and transparent communication practices.
Regulatory Compliance
The board meeting notification has been submitted under Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework mandates timely disclosure of board meetings to ensure market transparency and investor protection.
The communication was signed by Hansraj Singh, Company Secretary & Compliance Officer, and submitted to both National Stock Exchange of India Limited and BSE Limited on February 06, 2026.
Historical Stock Returns for Vijaya Diagnostic Centre
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.64% | +2.80% | -8.59% | -9.95% | -16.79% | +55.65% |


































